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1. Introduction 
The stepwise technique for ablation permanent atrial fibrillation (AF) is a combination and 
cumulative effect of several strategies (Calkins et al., 2009); pulmonary vein isolation (PVI), 
ablation of complex fractionated potentials, and linear lesions. This approach leads to 
termination of AF in 85% of cases without the need for pharmacological or electrical 
cardioversion and also produces unprecedented clinical outcomes in terms of maintaining 
sinus rhythm (SR) in the medium term, although more than 50% of patients require repeat 
procedures (Haissaguerre et al., 2005; O’Niell et al., 2006; Takahashi et al., 2007, Hocini et al., 
2010).  The cumulative effect of each step can be visualized as in figure 1. Termination of AF 
may occur at any point throughout the stepwise approach. The endpoint of ablation is 
termination of AF directly to SR (15%) or through intermediate atrial tachycardias (AT) with 
a mean of 2.6 atrial ATs per patient (Haissaguerre et al., 2005). With sinus rhythm 
successfully restored, the PVI and integrity of any linear ablation should be confirmed and if 
incomplete finished by further ablation as necessary, now in sinus rhythm. 
 
Fig. 1. Shows the cumulative effect of the stepwise ablation: with each next step, more 
termination of AF. The incremental benefit of each next step has a progressively smaller 
effect, until a ceiling of about 85% after which more ablation will not result in a higher 
success rate for AF termination (Hocini et al., 2010). PV Pulmonary Veins, RSPV and RIPV 
right superior and right inferior pulmonary veins respectively. LSPV and LIPV left superior 
and left inferior pulmonary veins respectively. MA mitral annulus. CS coronary sinus. 
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This chapter will go through in detail each step of this ablation approach. In addition, 
patient selection and preparation as well as post procedural care and complications will be 
described. Atrial tachycardia mapping and ablation will be described although it is not in 
the scope of this chapter to give a full description of this large topic. Finally, procedural 
outcomes and predictors of success will be discussed.  
It should be emphasized that this chapter will describe the way the authors carry out their 
ablation procedures, there are many variations between centers, but generally the 
similarities in approach far outweigh any differences.  
2. Patient selection and pre-procedural preparation 
Persistent AF is defined as AF which that is sustained beyond seven days, or lasting less 
than seven days but necessitating pharmacologic or electrical cardioversion to restore 
sinus rhythm. Included in the category of persistent AF is “longstanding persistent AF” 
which is defined as continuous AF of greater than one year duration. Patients with 
symptomatic persistent AF who are refractory to antiarrhythmic drug therapy are 
candidates for the procedure if they accept the benefits and risks, as well as a >50% 
chance of requiring a second procedure. Catheter ablation of AF is a demanding 
procedure that may result in severe complications, a fact that should be explained to the 
patient prior to signing any consent form. Patients are not excluded on the basis of LA 
size or the presence of concomitant structural heart disease.  On the contrary, selected 
patients with heart failure and/or reduced ejection fraction especially seem to benefit 
from restoration of SR. 
2.1 Patient preparation 
All patients undergo cardiac evaluation with imaging pre-procedure. A standard two-
dimensional echocardiogram is most commonly used. Besides standard parameters such 
as atrial dimensions and ventricular function, other abnormalities such as an interatrial 
septal aneurysm or a persistent foramen ovale are actively sought for by the 
echocardiographer. 
A transesophageal echocardiogram (TEE) is performed in all patients prior to the procedure 
to exclude LA thrombus, which is present in approximately 1% of cases despite appropriate 
anticoagulation and irrespective of the patients’ CHADS2 score (Scherr et al., 2009). The TEE 
is usually performed the day before to the procedure. 
All antiarrhythmic drugs are stopped for at least 5 half lives prior to ablation except in the 
case of amiodarone, which is continued.  
2.2 Pre-procedural advanced cardiac imaging 
Computed tomography (CT) and magnetic resonance imaging (MRI) are increasingly used 
pre-procedure in order to gain more detailed atrial anatomical knowledge as well as for 
possible merging with 3-D electroanatomical mapping systems (see below).  In addition, 
MRI can assess for areas of delayed enhancement (suggesting fibrosis/scar areas) but for 
now this additional information is usually part of research. However, neither current 
evidence nor personal experience has convinced us to routinely use pre-procedural 3D 
imaging and/or 3D electroanatomic mapping for every AF ablation procedure. 
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2.3 Anticoagulation 
Patients are treated with oral anticoagulants to maintain an international normalized ratio 
(INR) between 2 and 3 for at least four weeks leading up to the ablation, with cessation 48 
hours prior to the procedure. Patients with a contraindication to warfarin or who refuse oral 
anticoagulation are treated at the physician’s discretion. Patients do not routinely receive 
bridging therapy with low molecular weight heparin between the cessation of warfarin and 
the procedure. However, in selected patients with major risk factors, e.g. prior embolic event 
or an enlarged LA with spontaneous contrast, low molecular weight heparin is administered 
as a bridging therapy. 
3. Patient preparation and ablation set-up 
The vast majority of our patients undergo the AF ablation procedure under conscious 
sedation and not under general anaesthesia, aiming to prevent and monitor for any 
complications such as cerebrovascular embolic events. Sedation is with midazolam and 
morphine, if any deeper sedation needed, this should be anaesthetist-guided. Arterial lines, 
urinary catheters or esophageal temperature probes are not routinely used. 
One 6 French sheath and two 8 French sheaths (one of which is later replaced with the 
transseptal sheath) are placed in the right common femoral vein and a decapolar steerable 
catheter is placed in the CS such that its tip is at the 3 o’clock position in the 30° LAO view.  
3.1 Rotational atriography and pulmonary vein angiography 
Prior to the transseptal puncture 3D rotational atriography of the LA and pulmonary veins 
is usually performed (using a Philips Xper FD 10 system (Philips Medical Systems, Best, The 
Netherlands)). This is done by placing a 6 Fr pigtail catheter in the upper end of the inferior 
caval vein, with the C-arm carefully isocentered over the LA, and then injecting contrast. 
After a standard delay, usually 14 seconds (pulmonary transit time), the fluoroscopy is 
initiated and the C-arm rotates over a 240° arc with an X-ray acquisition speed of 30 
frames/sec. The 3D data are automatically transferred and merged onto the workstation to 
enable on-line 3D reconstruction and as such catheter visualisation in 3D on-line. Details of 
rotational atriography are described elsewhere (Knecht et al., 2010). This gives very useful 
acute and precise anatomical definition of the ostia and hence help guide the ablation and 
minimises complications such as pulmonary vein stenosis, which can occur if ablating too 
distal into the vein.  
A (less ideal) alternative to 3D atriography is selective angiography of the pulmonary veins. 
This is done by selectively engaging each of the four PV ostia with a multipurpose 
angiography catheter and injecting contrast media into each vein under fluoroscopy. 
3.2 Transseptal puncture 
Several different techniques are used to obtain a safe transseptal puncture. Centers should 
probably continue what they are experienced with and feel competent with. Here we 
suggest one way of proceeding: an antero-posterior X-ray position is used for the pull-down 
(usually started with a 4- to 5 o’clock needle position) and, once the jump onto the foramen 
ovale is seen, for the transseptal puncture. Before puncturing and crossing the needle into 
the left atrium, the monoplane fluoroscopy system is briefly positioned in a left-lateral 
position to check for needle position in the sagittal plane (ideally between 12 and 1 o’clock). 
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Single transseptal puncture is performed with pressure monitoring and using contrast 
injection through the needle tip to confirm LA access prior to advancing the dilator and 
sheath assembly. A guidewire is advanced through the dilator and sheath assembly into a 
left PV and the dilator and sheath are pulled back into the RA to allow passage of the 
ablation catheter through the same puncture site into the LA (hence a single puncture 
technique). The dilator and sheath are then advanced over the guidewire into the LA 
alongside the ablation catheter, the sheath is aspirated and initially flushed with a bolus and 
subsequently continuously with heparinized saline at 200 ml/hr. Immediately after LA 
access, a bolus of heparin (50U/kg) is given intravenously. The ACT is checked every 30 to 
60 minutes during the procedure and repeat boluses of heparin is administered to achieve a 
constant activated clotting time (ACT) between 250-300 seconds. 
3.3 Sheaths and catheters 
A 10-pole, 20 mm circular decapolar catheter is advanced via a transseptal sheath (SL-0, St. 
Jude Medical, St. Paul, Minnesota) and positioned just distal to the PV ostia to map the PV 
perimeter during PVI.  An externally irrigated tip ablation catheter (eg Thermocool 3.5 mm–
tip catheter, Biosense Webster Inc, Diamond Bar, CA) is used, usually with an F-curve, 
however, the size of the curve used should depend on the size of the atrium.  
3.4 Radiofrequency delivery 
Radiofrequency energy is delivered using a Stockert generator (Biosense Webster) with the 
power settings shown in Table 1. These power settings have been determined empirically to 
provide effective lesions while also minimizing the risks of PV stenosis, steam pops, cardiac 
tamponade and collateral damage to the phrenic nerve, esophagus and circumflex coronary 
artery. Target temperatures of 40-42°C are achieved (maximum temperature 45°C) by 
manual titration of irrigation rates from 5-60 ml/minute (0.9% saline via CoolFlow pump, 
Biosense Webster).   
 
Ablation site Power (Watts) Usual  total duration of 
radiofrequency delivery 
(mins) 
Coronary Sinus 15 -25 4-8 
Posterior wall LA 25 - 30 3-6 
Anterior wall LA 30 - 35 3-6 
Inferior LA 30 – 40 5-10 
Roof LA 25 – 30 10-15 
PVs 30 25-40 
Septum LA 30 3-6 
Right atrium 20 – 35 0-20 
Mitral Isthmus 30 – 35 10-20 
Table 1. The power settings and usual RF delivery time at each anatomic region.  
3.5 Signal processing  
During AF ablation procedures, 12 lead surface electrocardiograms and bipolar endocardial 
electrocardiograms are continuously monitored and stored using a digital amplifier and 
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computer recording system (LabSystem Pro, Bard Electrophysiology, Lowell, MA, USA). All 
signals are sampled at 1Khz with filter settings from 30 to 250Hz for intracardiac signals and 
0.1 to 50Hz for surface electrocardiograms. Intracardiac signals are displayed at an 
amplification of 0.1mV/cm and with a gain of x16 for the mapping/ablation catheter, and 
0.2mV/cm with a gain of x8 for the Lasso catheter and coronary sinus catheter.  
3.6 Three dimensional mapping 
While not routinely required, various 3-D electroanatomic mapping technologies may be 
used for assessment of anatomy, electrogram analysis, and quantification of the impact of 
ablation on LA and RA voltages.  Occasionally, these technologies are useful for mapping 
ATs that may arise after AF termination or during subsequent procedures. Any 
electroanatomic mapping system may be used (EnSite NavX Navigation & Visualization 
Technology, St. Jude Medical, St. Paul, MN; CARTO3 System, Biosense Webster, Diamond 
Bar, CA), which allow real-time display of any cardiac catheter during ablation. The ability 
to display a lasso catheter allows for very rapid creation of a left atrial map and direction of 
the ablation catheter toward the desired poles on the lasso catheter. 
3.7 Atrial Fibrillation cycle length 
Assessment of the atrial fibrillation cycle length (AFCL) is an important tool in guiding the 
ablation procedure. Electrograms (EGMs) in persistent AF are complex and the cycle length 
cannot be reliably measured, except in the right and left appendages (Figure 2). Throughout 
the stepwise ablation the AFCL will gradually prolong and once a critical prolongation has 
been achieved, usually in the region of 180 to 200 ms, the atrium can no longer sustain the 
fibrillatory process and AF terminates to either SR or, as in the majority of cases, to an atrial 
tachycardia (AT) that can then be mapped and ablated conventionally.   
 
Fig. 2. Surface leads I, II, III and V1. Then the EGMs of the radiofrequency (RF) catheter, RFp 
(proximal) and RFd (distal), placed in the inferior LA. PV1-PV10 are the EGMs from a 
LASSO catheter placed in the left atrial appendage (LAA). CS 1-10 are the EGMs from a 
decapolar catheter in the coronary sinus. The AFCL cannot be measured on the surface ECG 
nor in the coronary sinus. However the LASSO catheter in the LAA enables measurement a 
more exact AFCL, here 10 cycle lengths are counted, giving an AFCL of 141ms.  
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4. Pulmonary vein isolation 
Ablation strategies which target the isolation of the PVs are the cornerstone for most AF 
ablation procedures. The PVs can be isolated individually or as ipsilateral pairs, generally 
dependent on venous anatomy, catheter stability and operator preference. When the PVs are 
targeted, complete electrical isolation and elimination of all electrical near-field signals 
around the PVs is the goal. An example of isolation of the left superior pulmonary vein 
(LSPV) can be seen in Figure 3. 
 
Fig. 3. Left panel shows surface ECG I, II, III and V1. Then, the RF ablation EGMs, followed 
by the poles 1-10 of the Lasso catheter and the lowest 5 EGMs are the bipoles of the 
decapolar catheter in the CS. The right panel shows fluoroscopy of the decapolar catheter in 
the coronary sinus, the Lasso catheter in the LSPV, and the RF catheter ablating just 
proximal to the ostium of the vein. There is 2:1 entry block into the vein prior to isolation.  
Ablation is performed 1 to 2 cm proximal to the PV ostia. The ablation is typically started on 
the posterior wall towards the LSPV. Ablation can be done in a continuous manner, 
delivering energy at any given site for 30 – 60 seconds, until the local electrical signals have 
diminished, before moving on to the next site in a continuous fashion, slowly creating a 
posterior ablation line (vertical line from high to low) on the left side, followed by ablation 
within the first millimeters of the venous ostia to target the fascicles lying anteriorly until 
electrical PV isolation. Circumferential ablation is then repeated around the right PVs with a 
continuous circular lesion. It is unusual to achieve PV isolation after circumferential 
coalescent lesions without further ablation targeting the earliest PV activity or sites of 
reverse PV polarity as recorded on the circumferential mapping catheter indicating the 
residual anatomical connection. During ongoing AF, the sequence of PV activation is 
incessantly changing because (i) multiple breakthroughs are present in the most veins, (ii) 
changing incident wavefronts of activation at the PV ostia and (iii) rate-dependent 
conduction properties of the LA-PV connections. A consistent activation sequence usually 
means discrete sites of breakthrough, either spontaneous or following prior ablation.  
Delivery of RF narrows the width or number of LA-PV connections resulting in progressive 
consistency of the PV activation sequence. The endpoint of this step is complete electrical 
isolation of all pulmonary veins evident in the form of entrance block. 
During AF, it can be difficult to distinguish far field potentials from local pulmonary vein 
potentials, both seen on the circular catheter at the PV ostium. Some guides to the 
differentiation are as follows: 
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-  PV potentials represent local myocardial activation and therefore exhibit sharper 
electrograms with more rapid deflection than the far-field potentials. 
- Activation sequence of PV potentials is constantly changing during ablation, while that 
of far-fields is relatively stable.  
- Consistent prolongation of PV CL may be observed due to reduction of LA to PV 
connections with radiofrequency applications. 
- If doubt remains, far-field potentials can be unmasked by putting a recording catheter 
in the suspected structure, in particular the LAA. Synchronous activity between LAA 
and PV potentials confirms an external origin of potentials recorded on the 
circumferential catheter. 
As previously explained, long-standing persistent AF will terminate after PVI alone only in 
a small minority of patients although the global AFCL usually increase by 8ms 
(Haissaguerre et al., 2005a).  Once sinus rhythm is restored, after the stepwise ablation 
approach, it is important to confirm complete PVI, this is best done by re-inserting the 
circumferential lasso catheter into each vein.  
Figure 4 shows the AFCL prolongation achieved following pulmonary vein isolation. This 
tracing is from the same patient as who had an AFCL of 141ms in figure 2 and PVI in figure 3. 
 
 
Fig. 4. Upper panel shows the surface leads I, II, III and V1. The EGMs from the RF catheter 
(placed at the base of the LAA) and lowest the EGMs from the 5 bipoles of the decapolar 
catheter in the CS. The AFCL is now 159ms. Lower panel shows the catheter placement on 
fluoroscopy. 
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5. Electrogram- based ablation during disorganized left atrial activity 
The next step in the approach is electrogram based ablation, also colloquially called 
defragmentation. Following pulmonary vein isolation left atrial activity is usually chaotic 
with disorganized sites everywhere and the overall activity is too complex to map in terms 
of activation, morphology or local cycle length. The aim is to ablate favorable areas that 
would result in slowing and organization of global LA activity.  
5.1 Targets for EGM-based ablation 
Favorable areas in the left atrium for ablation are continuous electrograms with complex 
fractionated potentials that are noted at first sight, especially when the AFCL is around 140-
150ms. When the AFCL prolongs significantly, we search for sites with a gradient of 
activation (significant electrogram offset between the distal and proximal recording bipoles 
on the map electrode), or regions with a cycle length that are shorter that the mean LAA 
cycle length (Haissaguerre et al., 2005). A recent study found that ablation of areas with 
continuous activity had the greater impact on AFCL prolongation and AF termination than 
ablation of areas with high fractionation index, EGM voltage and local cycle length 
(Takahashi et al., 2008).  
The various zones of complex atrial electrograms may be explained by several different 
underlying etiologies. They may represent areas of colliding wave fronts, pivot points of 
moving wavelets or collision with barriers such as scars or existing structures for instance 
valves or appendages. Complex electrograms are seen in the periphery of sites of rapid 
activity, often with a frequency gradient to surrounding tissue. These sites are usually 
located at the base of the LAA, the PV ostial region and in the inferior LA along the CS. 
Figure 5 shows examples of complex electrograms.    
 
Fig. 5. Shows simultaneous recordings from the RF (in the LA) and CS catheters ; panel A is 
a recording of continuous activity on the RF catheter without a return to baseline, panel B 
shows a fractionated potentials on the RF catheter with an interposed isoelectric interval  
and panel C is an example of rapid activity recorded on the RF catheter with a frequency 
gradient to the CS.   
5.2 Facilitating tools in localizing targets for ablation 
Localizing and mapping areas for electrogram based ablation can be difficult. To facilitate 
this, various methods have been tried, including anatomical guided ablation, the use of 
multipolar catheters and the use of 3 dimensional mapping systems. 
www.intechopen.com
 Stepwise Ablation of Permanent Atrial Fibrillation 
 
223 
5.2.1 Anatomical guidance to defragmentation 
Studies have been done to try determine anatomical areas within the left atrium where 
ablation has the greatest impact (rise in the LAA-AFCL by at least 5ms) on the AF process; 
in addition to the pulmonary vein isolation, the base of the left atrial appendage and the 
interface between inferior LA and the coronary sinus has the greatest impact (Haissaguerre 
et al., 2005). Figure 6 illustrates this concept. Figure 7 is an example of ablation of chaotic 
EGMs in the inferior left atrium. 
 
Fig. 6. With ablation of each anatomical area the AFCL gradually prolongs – a cumulative 
effect. 
 
Fig. 7. Surface leads I,II III and VI. The EGMs on the RF catheter are of a complex nature. 
The decapolar catheter in the CS confirms AF. Ablating in the inferior LA can be done by 
dragging the catheter along the floor of the atrium, either from left to right (upper insert) or 
from right to left (lower insert). 
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5.2.2 Multipolar catheters 
Another aid in determining left atrial areas/zones for ablation is the use of multipolar 
catheters, such as the LASSO catheter or the PENTA-RAY catheter (Biosense Webster, Inc, 
Diamond Bar, CA, USA), with 10 and 20 poles respectively (figure 8).  The advantage, apart 
from the high density of electrograms, is the temporal and directional information such 
closely organized catheter poles can provide. These catheters are particularly useful in 
organized atrial fibrillation, as well as in mapping focal and localized re-entrant 
tachycardias (an example described below). 
 
Fig. 8. Examples of multipolar catheters that can be used for mapping, to the left a spiral 
catheter, to the right a penta-ray catheter. 
5.2.3 Three dimensional mapping systems 
Finally, an aid can be 3 dimensional mapping systems that have algorithms to compute (on-
line) areas of very short cycle lengths and fragmentation. Figure 9 shows an example of a 
NAVx (St Jude Medical, Inc., MN, USA) eletroanatomic fractionation map of the left atrium 
during atrial fibrillation. The most fractionated (fastest cycle length) areas are represented 
by red, the least represented by blue, and grey represents scar or inactive areas. 
 
Fig. 9. Shows a NAVx electroanatomic fractionation map of the left atrium (postero-anterior 
view). Circumferential PVI can be seen represented by brown ablation points. 
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5.3 Cycle length prolongation 
Throughout the defragmentation the AFCL is prolonging and it useful to assess the AFCL 
after each step of ablation. Figure 10 illustrates the prolongation during defragmentation in 
the same patient as earlier. He had an initial AFCL of 141ms (figure 2) which prolonged to 
159ms after PVI (figure 4). During defragmentation in the inferior LA, base of LAA and 
septum the AFCL prolonged to 183ms and during roof ablation converted to an AT (figure 
10). 
 
Fig. 10. Both panels show surface leads I, II, III, VI and a decapolar catheter in the CS. In the 
upper panel the RF catheter is in the LAA and the AFCL is measured over 10 cycles to be 
183ms. With further ablation the AF converts to an AT (lower panel).  
6. Linear ablation 
If the patient is still in AF after the previous steps, the next stride in the stepwise ablation 
procedure is linear ablation. Linear ablation is an important tool in the step wise ablation 
procedure (Knecht et al., 2008). The efficacy of linear lesions may be related to interruption 
of wavelets and macro re-entries, ablation of autonomic innervations and atrial debulking. 
The left atrial roof and the lateral mitral isthmus are the most common sites for linear 
ablation. Linear ablation is often done during AF but proving bidirectional block can only be 
done in SR, usually towards the end of the procedure when SR has been reestablished. It is 
possible that that the previous steps have rendered the patient in an atrial tachycardia, in 
which case the lines are ablated (if appropriate) during the AT.  
In general, linear ablation is the last step in the stepwise approach. This is because they can 
be very difficult, they may require not only a long time but also a large amount of 
radiofrequency to successfully achieve bidirectional block. This alone increases the risk for 
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complications such as perforation and tamponade. In addition incomplete lines are 
associated with arrhythmia recurrence and pro-arrhythmic effects (Gerstenfeld etal., 2004; 
Chugh et al., 2005). The 2 left atrial lines will be discussed separately. 
6.1 Linear ablation at the left atrial roof 
The left atrial roof line is relatively short, forming a continuous line between the already 
isolated left and right superior pulmonary veins.  In the vast majority of patients this step is 
done during AF and the end point (during AF) is 85-90% diminution or complete abolition 
of local electrograms along the line. The line is performed as cranially as possible to avoid 
ablating the posterior LA, hence aiming to avoid complications such as damage to the 
esophagus.  
The electrophysiological endpoint of roof ablation is the creation of a complete line of 
conduction block between the superior PVs. If the ablation is done during AF, 
supplementary ablation during sinus rhythm is usually required.  Electrical block is 
confirmed in all patients following restoration of SR using a well described technique 
(Hocini et al., 2005).  
6.1.1 The creation of the roof line 
The ablation catheter is curved and dragged along the line with the tip of the irrigated 
catheter positioned parallel to the roof, either from right to left or left to right. A large loop 
in the LA is often helpful (figure 11). If the orientation of the catheter tip is perpendicular to 
the roof power settings should be reduced (to 25W) to lessen the possibility of steam pops 
and perforation. 
 
 
 
Fig. 11. Surface lead I, II and VI together with the EGMs from the RF. This roof line is carried 
out during roof dependent atrial tachycardia; fractionated EGMs can be seen on the RF 
catheter prior to completion of the line when the SR is restored.  
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6.2 Linear ablation at the mitral isthmus 
Ablation of the mitral isthmus, achieving bidirectional conduction block further increases 
the success rate of catheter ablation in persistent AF (Jais et al., 2004). In general this ablation 
step in only carried out if deemed necessary; if the previous steps have not terminated the 
atrial fibrillation or if the patient is in an mitral isthmus dependent atrial tachycardia. If the 
line is carried out during AF, the endpoint is the same as that for the roof line; abolition of 
all local electrograms along the line, usually with the creation of double potentials all along 
the line. If carried out during atrial tachycardia (mitral isthmus dependent flutter) the goal is 
arrhythmia termination. Once in SR, the electrical block must be confirmed using 
bidirectional pacing and sensing from the CS catheter and the mapping catheter (see below). 
Again, it is likely that more ablation is needed once in sinus rhythm to achieve bidirectional 
block. It must be noted that even in the best pair of hands, block of the mitral isthmus 
cannot be achieved in about 10% of patients. 
6.2.1 The creation of the mitral isthmus line 
The mitral isthmus is short, 2-4cm, from the mitral annulus to the left inferior pulmonary 
vein ostium (or the left atrial appendage). It is often needed to extend the line from the 
ostium of the inferior pulmonary vein to the base of the LAA in order to achieve block as 
well as it is needed in up to 80 % to  ablate within in coronary sinus to achieve block (Jais et 
al., 2004).  The mitral isthmus line is begun at the ventricular aspect of the mitral annulus, 
see figure 12. With clockwise rotation on the sheath and catheter the lesion is extended to 
the left inferior PV and further to the base of the LAA if needed. If mitral isthmus block is 
not achieved by this, the ablation is extended to the epicardial aspect of the mitral isthmus, 
via the coronary sinus (Jais et al., 2004). The overall goal remain the same for all linear 
lesions, elimination of local EGMs along a line connecting 2 electrically inactive sites, e.g. the 
mitral valve annulus and the encircling lesion of the LIPV. 
 
Fig. 12. Surface leads I, II and VI, the RF catheter and the bipolar EGMs of the decapolar 
catheter in the CS. The RF catheter is at the start of the linear ablation of the mitral isthmus. 
Often there are high amplitude EGMs at the mitral isthmus pre ablation.  
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7. Right atrial ablation 
In 15% of patient with persistent AF, SR cannot be restored by ablation in the LA and the 
presence of perpetuators in the RA should be considered (Hocini et al., 2010). This state of 
affairs should be suspected when the AFCL in the RAA prolongs less than the AFCL in the 
LAA during ablation; a shorter AFCL in the RAA compared to LAA can be due to the 
drivers of AF originating in the RA (figure 13). Similarly, pauses in activity in the LA 
electrograms without corresponding pauses in the RA electrograms would suggest the RA 
as the driving chamber. The approach to mapping and the electrogram ablation within the 
RA is the same as for the LA.  Preferential anatomical areas at which there is a higher 
incidence of AF termination during ablation of complex fractionated atrial electrograms are 
the right atrial appendage, the intercaval region, the SVC and the CS ostium. 
 
Fig. 13. Shows surface lead VI, EGM from the RF catheter placed in the LAA and the 5 
bipolar EGMs from the LASSO catheter placed in the RAA as the lower 5 rows. The LAA 
AFCL is 167 and the RAA AFCL 156 suggestive of a driving source in the right atrium. The 
right hand panel is a fluoroscopy of the catheter placement. 
8. Atrial tachycardia in the context of atrial fibrillation ablation 
Atrial tachycardia may occur at any point throughout the stepwise ablation for atrial 
fibrillation; when the AFCL is so prolonged that the LA can no longer sustain the fibrillatory 
process. As described in the introduction, the endpoint of the stepwise ablation is 
restoration of sinus rhythm, and this re-establishment of sinus rhythm usually occurs via 1 
or more ATs (Haissaguerre et al., 2005). In addition, AT is the dominant mode of arrhythmia 
recurrence in patients in whom AF was terminated during the index procedure (O’Neill et 
al., 2009). 
Atrial tachycardia is characterized by a monomorphic P-wave and a consistent intracardiac 
activation sequence. In the context of AF ablation, we classify AT into three categories:  
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Macro re-entry is defined as a circuit involving 3 or more atrial segments, and where more 
than 75% of the circuit can be mapped.  
Focal tachycardia is defined as centrifugal activation originating from a discrete site, and 
where <75% of the cycle length can be mapped. This tachycardia can be due to any of 
increased automaticity, triggered activity or re-entrant mechanisms. 
Localized re-entry constitutes a circuit involving 1 or 2 adjacent segments, usually smaller 
than 2 cm in diameter and spanning more than 75% of the cycle length within the involved 
segments. 
A recent series of 238 ATs occurring after ablation of persistent atrial fibrillation found that 
46% were macroreentrant and 54% focal or microrentrant ATs. Of the macroreentrant 
tachycardias the commonest were perimitral circuits (56%), followed by roof dependent 
circuits (28%), and with a smaller proportion of tricuspid isthmus dependent circuits (16%) 
(Jais et al., 2009). More complex macro-reentrent circuits are less common e.g. double loop 
re-entry and circuits passing through gaps between the pulmonary veins and/or the LAA.  
8.1 Mapping atrial tachycardias 
An approach to mapping atrial tachycardias is shown in figure 14. The first step is to assess 
atrial tachycardia cycle length variation, if > 15% variable the AT is likely to be of focal or 
local re-entry aetiology, if < 15% the tachycardia can be of any of the 3 categories (Jais et al., 
2009). Fig 15 is an example of a tachycardia with very little cycle length variation. If the cycle 
length variation is less than 15% the first aim is to deduct whether it is a macroreentrant 
tachycardia or of a focal source. This requires activation mapping and entrainment 
mapping. If the cycle length variation is more than 15% and the atrial tachycardia 
mechanism therefore most likely a focal or localized re-entry source, the aim then is to map 
the source. 
 
Fig. 14. Shows an algorithm for the diagnosis of atrial tachycardias. 
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Fig. 15. Shows a tracing of an atrial tachycardia with very little cycle length variation, in this 
case 3%. The AT can therefore be either any of the 3 categories of AT: focal, localized re-
rentry and macroreentrant. In such case, the first step is to rule in, or rule out, a 
macroreentrant tachycardia using activation mapping and entrainment. This tracing is from 
the same patient as in figures 2, 3, 4 and 10. 
8.1.1 Mapping macro reentrant tachycardias 
If the AT CL variation is more than 15%, the first aim is to rule in or rule out a macro re-
entrant tachycardia. Given that the majority of macroreentrant AT are one of the following 
three: 1) Mitral isthmus dependent flutter (Perimitral AT), 2) Roof dependent flutter and 3) 
Cavotricuspid isthmus dependent flutter (Peritricuspid AT); activation mapping around the 
mitral annulus, anterior and posterior LA, the roof and the tricuspid annulus are mapped to 
look for the presence of activity all through the period of one tachycardia cycle length. Each 
of the 2 left atrial circuits has their own distinct activation sequence of the LA (figure 16): 
 
Fig. 16. Depicts the left atrial activation pattern of the macro reentry circuits: 
counterclockwise peri-mitral (A) and roof dependant (B) 
Once the activation pattern of the macro-reentrant tachycardia has been established, 
entrainment from at least 2 opposite segments should be done to confirm (or rule out) the 
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diagnosis. If macro re-entrant circuits are ruled out the algorithm leads back to the top of the 
arm for focal and localised re-entrant tachycardias.  
8.1.2 Ablating macroreentrant tachycardias 
The perimitral atrial tachycardia passes through the mitral isthmus between the mitral valve 
annulus and the left inferior pulmonary vein, and hence ablation with complete isthmus 
block abolishes this arrhythmia. The roof dependent flutter is dependent on the relatively 
narrow part between the 2 upper pulmonary veins and a complete ablation line would 
terminate roof dependent flutter. The ablation of these two lines is described above. It is not 
in the scope of the chapter to describe the ablation of the right atrial peritricuspid flutter. 
8.1.3 Confirming bidirectional block following line ablation – roof line 
This very important step is undertaken after the SR has been restored, either from the 
stepwise ablation, or form direct current cardioversion. Following a complete roof line, 
pacing of the LAA will result in the activation of the posterior LA from inferior to superior 
direction as the activation front cannot travel posteriorly over the blocked roof. Figure 17 
illustrates this concept. 
 
Fig. 17. The left panels show the surface leads I, II, III and VI. Then the EGMs of the RF 
catheter and lowest the 5 bipoles of the decapolar catheter – now placed though the 
transseptal puncture to the LAA. Pacing is done from the distal CS (LAA). In Panel A the RF 
catheter is placed low on the posterior wall and in panel B high on the posterior wall. 
During pacing from the LAA the time to low posterior wall is 162ms and to high posterior 
wall 184ms – thereby proving roof block.  
8.1.4 Confirming bidirectional block following line ablation – mitral line 
Following a mitral isthmus line, block is confirmed using differential CS pacing and pacing 
from the RF catheter at the lateral LA just anterior to the mitral line or in the LAA. In the 
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presence of block the activation front moves along the anterior wall to the septum and then 
along the posterior wall, septal to laterally, during LAA pacing. This gives a proximal to 
distal activation sequence of the CS. Figure 18A illustrates this. In the other direction, block 
is assessed by pacing the first the distal poles of the CS catheter, which is near the mitral line 
and measuring the delay to LAA. The pacing is then changed to a more proximal pole 
wherefrom the delay to the LAA should be shorter in the presence of blocked linear lesion. 
Figure 18B illustrates this.  
18 A 
 
18 B 
 
Fig. 18. A and B. The left panels show surface leads I, II, III and VI, then the RF catheter 
placed just anterior to the mitral line. Lowest is the EGMs of the bipoles of the decapolar 
catheter in the CS. In figure 18A pacing from the RF catheter confirms clockwise block over 
the mitral line by activating the CS catheter in a proximal to distal manner. Figure 18B 
confirms counterclockwise block by differential pacing, the pacing to RF is longer (138ms) 
when pacing the distal CS than when pacing the more proximal CS (98ms). 
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8.2 Focal and localized reentrant tachycardias 
After macroreentrant tachycardias have been ruled out the next step is tracking the earliest 
potentials for a focal or localized re-entry AT. Once the suspected region of origin has been 
found, careful mapping will suggest whether it is a focal or localized reentrant tachycardia. 
Local activity spanning most of the AT CL suggest local re-entry whereas if only a limited 
part of the CL can be mapped, the likely etiology is a focal tachycardia. Overall, these 2 
tachycardias are mapped and ablated in a similar manner.  
8.2.1 Mapping focal and localized reentrant tachycardias 
The aim is to gradually ‘pinpoint’ on the earliest spot. Often multipolar catheters can be 
helpful in localizing the earliest spot, simply by their ability to cover a larger area. Figure 15 
was an example of an AT with a cycle length variation of 3% (same patient as in figure 2, 3, 4 
and 10), where activation mapping and entrainment ruled out a macro reentrant circuit. The 
earliest region was found to be on the posterior wall and to aid localize the very earliest site 
of activation a LASSO catheter was used to map the posterior wall in detail. Figure 19 
illustrates this: 
 
Fig. 19. Right panel shows the LASSO catheter on the posterior wall of the LA. The left panel 
shows surface leads I, II, III and VI at the top and the EGMs from a decapolar catheter in the 
CS at the bottom. The EGMS from the posterior wall shows the earliest potentials on the 
posterior wall to be near LASSO pole 7-8. 
8.2.2 Ablating focal and micro reentrant tachycardias 
Once the earliest potentials are located, be it a focal or localized reentrant tachycardia, 
ablation at the earliest point or at the site covering more than 90% of the tachycardia cycle 
length should eliminate the arrhythmia. Figure 20 shows the successful ablation of the 
tachycardia mapped in figure 19 with the lasso catheter to the posterior wall.   
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Fig. 20. Shows the successful ablation of the tachycardia mapped in figure 19. The LASSO 
catheter is replaced by an RF catheter and RF energy is applied to where the poles 7-8 were 
and the tachycardia converts to SR. This example is the same patient as in figures 2, 3, 4, 10 
and 11, and he has now completed the stepwise ablation. However, before leaving the 
catheter laboratory it is paramount to ensure complete PVI and complete electrical block of 
any lines, now in the re-established SR. 
9. Post procedural care 
Following ablation, the guiding sheaths are pulled out of the left atrium and heparin is 
stopped. Patients will typically lie flat for 6 hours after sheaths are pulled due to the large 
sheaths used. All patients are treated with warfarin after ablation. Patients receive 
subcutaneous heparin injections beginning on the evening of the ablation and continuing 
until the INR is therapeutic. Patients are usually subjected to echocardiography and 
observed 48-72 hours post-procedure prior to discharge.  
Patients are followed up closely for the year following an ablation procedure. At 3, 6 and 12 
months, patients are admitted to hospital for 24 hours and undergo clinical evaluation 
including exercise stress testing, ambulatory Holter monitoring and transthoracic 
echocardiography. After the procedure, warfarin is continued for at least six months, and 
guided thereafter by the presence or absence of conventional risk factors for 
thromboembolism and maintenance of sinus rhythm. Patients with a CHADS2 score ≥2 are 
kept on warfarin regardless of their rhythm outcome. All antiarrhythmic drugs are 
discontinued by 3-6 months except in case of recurrence.  In such case, patients are offered a 
repeat procedure.  
10. Complications  
Serious complications can occur during an ablation for permanent atrial fibriallation, and it 
is important that these (and their rate of occurrence) are carefully discussed with the 
patients prior to him or her signing the consent form. The major complications are described 
in detail in the task force on atrial fibrillation (Calkins et al., 2007) and anybody carrying out 
these ablations should probably familiarize themselves with this document. Overall, 
tamponade, pulmonary vein stenosis, atrio-esophageal fistula and/or death (so far not 
existent at our centre), air emboli and cerebrovascular or peripheral-vascular complications 
compile to a cumulative 2-3% complication rate.  
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11. Procedural outcomes 
The stepwise ablation of permanent atrial fibrillation leads to termination in 87% of patients 
(Haissaguerre et al., 2005a). In this series 23 of 53 patients had a repeat procedure for 
arrhythmia recurrence (mainly for 1 or more atrial tachycardias). After repeat ablation 95% 
of all patients were in sinus rhythm at 11+- 6 months.  
O’Neill (O’Neill et al, 2009) report similar results from a larger cohort (156 patients) 
achieving atrial fibrillation termination in 85% using the stepwise ablation approach in 
patients with persistent AF (ie termination by ablation alone, not requiring pharmacological 
and/or DC cardioversion). After 34 months follow up 95% of these patients were still in 
stable sinus rhythm, albeit 49% needed a repeat procedure. If AF termination was not 
achieved from ablation during the index procedure stable sinus rhythm was only found in 
52% at 34 months, again albeit a redo procedure in 70%. In the AF termination group 89% 
have stopped anti-arrhythmic medication, whereas in the non-termination group only 25% 
stopped their AADs. Subsequent studies both from our group (Takahashi et al., 2007; Hocini 
et al, 2010) as well as studies published form other groups (Rostock et al.,  2011) have 
reported the same findings; that the stepwise approach to ablation of persistent AF leads to 
unprecedented good clinical outcome.  
11.1 Predictors of success  
The duration of uninterrupted AF and AFCL has been shown to be independent factors 
predicting AF termination (O’Niell et al., 2009, Matsuo et al., 2009). If the duration of AF is 
less than 12 months there is a 90% chance of AF termination. This success rate gradually 
decreases to 54% if the duration of AF is more than 48 months. Similarly, the AFCL is a 
predictor of success, with a likelihood of AF termination of 95% if the AFCL is more than 
161ms, gradually decreasing to 50% likelihood of success with AFCL of less than 120ms. Left 
atrial size is also predictor for termination of AF (Matsuo et al., 2009).  Left ventricular 
ejection fraction, amiodarone use, troponin, procedure time and RF time did not reach 
statistical significance.  
Termination of AF by ablation is also a strong predictor of success with up to 95% of 
patients remaining in SR after almost 3 years after 1.5 procedures (Takahashi et al., 2007; 
Rostock et al., 2011). 
Fine atrial fibrillation, as measured by the fibrillatory (F-) wave on the surface ECG, has 
been shown to be a marker of longer lasting atrial fibrillation and larger left atrial size 
compared to patients with a more coarse AF. Coarse atrial fibrillation with F-waves ≥0.1mV 
in leads V1 and II of the surface ECG are correlated to younger age, a shorter AF history and 
a smaller left atrium. An F-wave amplitude of ≥ 0.7 mV predicts AF termination by ablation 
with a sensitivity and specificity of about 80%. Lastly, the smaller amplitude F-wave 
(<0.05mV) is associated with a higher AF recurrence rate as compared with higher F-waves 
(≥0.5mV) (Nault et al., 2009).   
12. Conclusion 
The stepwise ablation of permanent atrial fibrillation is a logical, patient tailored approach 
that is guided by electrophysiological endpoints. The method can lead to termination of AF 
in up to 85% of patients and render them arrhythmia free at least in the medium term, albeit 
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more than 50% of patients need more than 1 procedure to achieve sustained sinus rhythm. 
Termination of AF by ablation, mapping and ablation of all intermediate ATs, and linear 
blocks confirmed is associated with a better long-term clinical outcome than when AF is not 
terminated by ablation. 
Predictors of success in restoration of acute and sustained sinus rhythm include the duration 
of the continuous AF, mean baseline AFCL, age and the amplitude of the surface ECG 
fibrillatory waves. Understanding further baseline characteristics, both clinically and 
electrophysiologically, may help improving outcome and lead towards better patient 
selection criteria. 
It is not known how to forecast which patients will experience arrhythmia recurrence, but 
predictors are incomplete lines, either from recovery of conduction or deficient line-block at 
the time of creation. Both recovery of pulmonary vein conduction (Ouyang et al., 2005) and 
incomplete left atrial linear lesions (Knecht et al., 2008) are important factors for arrhythmia 
recurrence. However, this is by no means the cause of all recurrences, for example, about 
20% of recurrence of atrial tachycardia following the index procedure occurred from sites 
not previously ablated (O’Neill et al., 2009).   
Despite unprecedented success of the stepwise approach to catheter ablation of permanent 
AF, ignorance remains particularly interpreting signals during chaotic activation in the 
atrium and this needs much more work. We still have only rudimentary tools to help 
identify the individual elements involved in AF and there is still a long way to go until we 
fully understand and master this arrhythmia.   
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